DNLI Competitors & Alternatives
Compare Denali Therapeutics Inc with similar stocks in the same industry
Biotechnology
DNLI
Main Stock$18.41
Tradestie Score
56
Market Cap
$2.18B
Revenue Growth
-1.0%
Analyst Upside
+92.8%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$19.71
|
$3.31B | - | 46 | Compare |
|
SLNO
Soleno Therapeutics, Inc. Common Stock
|
$53.01
|
$3.20B | 27.5 | 48 | Compare |
|
MLYS
Mineralys Therapeutics, Inc. Common Stock
|
$20.55
|
$3.09B | - | 53 | Compare |
|
VKTX
Viking Therapeutics, Inc
|
$24.40
|
$3.08B | - | 50 | Compare |
|
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
|
$40.50
|
$3.03B | - | 48 | Compare |
|
XENE
Xenon Pharmaceuticals Inc
|
$35.34
|
$3.02B | - | 48 | Compare |
|
CGON
CG Oncology, Inc. Common stock
|
$61.71
|
$3.01B | - | 64 | Compare |
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
|
$2.92B | 38.3 | 50 | Compare |
|
RARE
Ultragenyx Pharmaceutical Inc.
|
$15.65
|
$2.89B | - | 40 | Compare |
|
IMVT
Immunovant, Inc. Common Stock
|
$28.41
|
$2.85B | - | 56 | Compare |
More DNLI Analysis
Data updated: Oct 24, 2026 | Industry: Biotechnology (SIC 2836)
219 stocks in this industry